poisar

Stocks · News reference

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — PETMED EXPRESS INC (PETS)

    Filed: 2026-09-28 AccNo: 0001040130-26-000057 Size: 336 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

  2. BenzingaBenzinga Insights

    Full Transcript: PetMed Express Q1 2027 Earnings Call

    On Thursday, PetMed Express (NASDAQ:PETS) discussed first-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts